These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32183142)

  • 1. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine.
    Puszko AK; Sosnowski P; Raynaud F; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance.
    Puszko AK; Sosnowski P; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
    Bioorg Med Chem; 2023 Oct; 94():117482. PubMed ID: 37774449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.
    Teesalu T; Sugahara KN; Kotamraju VR; Ruoslahti E
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16157-62. PubMed ID: 19805273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urea-Peptide Hybrids as VEGF-A
    Puszko AK; Sosnowski P; Rignault-Bricard R; Hermine O; Hopfgartner G; Pułka-Ziach K; Lepelletier Y; Misicka A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tLyp-1: A peptide suitable to target NRP-1 receptor.
    Larue L; Kenzhebayeva B; Al-Thiabat MG; Jouan-Hureaux V; Mohd-Gazzali A; Wahab HA; Boura C; Yeligbayeva G; Nakan U; Frochot C; Acherar S
    Bioorg Chem; 2023 Jan; 130():106200. PubMed ID: 36332316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
    Baek DS; Kim JH; Kim YJ; Kim YS
    Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach.
    Haspel N; Zanuy D; Nussinov R; Teesalu T; Ruoslahti E; Aleman C
    Biochemistry; 2011 Mar; 50(10):1755-62. PubMed ID: 21247217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A
    Puszko AK; Sosnowski P; Pułka-Ziach K; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2493-2497. PubMed ID: 31326342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
    Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA
    J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method.
    Puszko AK; Sosnowski P; Tymecka D; Raynaud F; Hermine O; Lepelletier Y; Misicka A
    Medchemcomm; 2019 Feb; 10(2):332-340. PubMed ID: 30881620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1.
    Parker MW; Linkugel AD; Vander Kooi CW
    J Mol Biol; 2013 Nov; 425(22):4405-14. PubMed ID: 23871893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
    Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y
    Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
    Roth L; Prahst C; Ruckdeschel T; Savant S; Weström S; Fantin A; Riedel M; Héroult M; Ruhrberg C; Augustin HG
    Sci Signal; 2016 Apr; 9(425):ra42. PubMed ID: 27117252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
    Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
    FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.
    Mota F; Yelland T; Hutton JA; Parker J; Patsiarika A; Chan AWE; O'Leary A; Fotinou C; Martin JF; Zachary IC; Djordjevic S; Frankel P; Selwood DL
    Chembiochem; 2022 Jan; 23(1):e202100463. PubMed ID: 34647407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A
    Masłowska K; Witkowska E; Tymecka D; Halik PK; Misicka A; Gniazdowska E
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35056995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa.
    Pemmari T; Ivanova L; May U; Lingasamy P; Tobi A; Pasternack A; Prince S; Ritvos O; Makkapati S; Teesalu T; Cairo MS; Järvinen TAH; Liao Y
    Mol Ther; 2020 Aug; 28(8):1833-1845. PubMed ID: 32497513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1.
    Grabowska K; Puszko AK; Lipiński PFJ; Laskowska AK; Wileńska B; Witkowska E; Misicka A
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2843-2846. PubMed ID: 27142754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity.
    Jia H; Aqil R; Cheng L; Chapman C; Shaikh S; Jarvis A; Chan AW; Hartzoulakis B; Evans IM; Frolov A; Martin J; Frankel P; Djordevic S; Zachary IC; Selwood DL
    Chembiochem; 2014 May; 15(8):1161-70. PubMed ID: 24771685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.
    Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A
    Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.